Gentherm Stock Price, News & Analysis

Gentherm (NASDAQ:THRM) will announce its financial results for Q4 and year-end 2020 on February 19, 2021, at 6 a.m. ET, followed by a conference call at 8 a.m. ET. The call can be accessed via a toll-free number or an international dial-in. A live webcast will also be available on Gentherm's Investor Relations website, with a replay accessible for one year. Gentherm develops thermal management technologies for automotive and medical applications, employing over 11,000 people worldwide.

Gentherm (NASDAQ: THRM) announced the appointment of Betsy Meter to its Board of Directors, effective January 8, 2021. Meter, a former Managing Partner at KPMG Michigan, brings extensive experience in accounting and operational issues, particularly in the automotive sector. Her strategic insights and strong industry network are expected to enhance shareholder value as Gentherm pursues its Focused Growth strategy. This appointment marks an important step in promoting diversity within the Board, now comprising three female members.

Gentherm (NASDAQ:THRM) announced the appointment of Steve Fletcher as the new Senior Vice President and General Manager of its Medical business. Fletcher, who has extensive experience in medical technology, will drive profitable growth and product development while aligning with the company's automotive product lines. Gentherm's CEO, Phil Eyler, expressed confidence in Fletcher's ability to enhance the company's leadership in patient temperature management solutions. Fletcher previously held roles at C2 Sense and Thermo Fisher Scientific.

Gentherm (NASDAQ:THRM), a leader in thermal management technologies, announced that CEO Phil Eyler will participate in a virtual fireside chat during the 19th Annual J.P. Morgan Tech/Auto Forum on January 12, 2021, at 12:25 pm PT (3:25 pm ET). A live audio webcast will be available, with a replay accessible for 45 days on Gentherm's Investor Relations page. The company specializes in heating and cooling systems for various applications, including automotive and medical sectors, with over 11,000 employees worldwide.

Gentherm (NASDAQ:THRM), a leader in thermal management technologies, has rescheduled its conference call to discuss Q3 2020 financial results to 11 am ET on October 29, 2020. Investors can dial in using the toll-free number 1-855-327-6837 or access via the webcast available on the company's website. A replay will be available two hours post-call until November 12, 2020 at 11:59 p.m. ET. Gentherm specializes in innovative thermal products across various sectors, employing over 11,000 personnel globally.

Gentherm (NASDAQ:THRM) announced a delay in its conference call scheduled to discuss third-quarter financial results for 2020 due to technical issues with their service provider. The company will inform stakeholders of the new date and time once a solution is in place.

Gentherm specializes in innovative thermal management technologies across various sectors, including automotive and medical applications, and employs over 11,000 people globally.

Gentherm (NASDAQ:THRM) reported a strong financial performance for Q3 2020, with product revenues reaching $259.5 million, an 8.1% year-over-year increase. The company achieved a record quarterly gross margin of 31.8% and adjusted EBITDA of $50.1 million, reflecting a 23.1% increase from the previous year. GAAP diluted earnings per share rose to $0.73, up from $0.48. New business awards in the automotive sector totaled $80 million. Despite macroeconomic uncertainties, Gentherm's performance underscores its strategic growth initiatives in thermal management solutions.

Gentherm (NASDAQ:THRM), a leader in thermal management technologies, announced that Phil Eyler, President and CEO, will present at Baird’s 2020 Global Industrial Conference on November 12, 2020, from 7:55 to 8:25 am (ET). This presentation will be available via a live audio webcast and a replay for 45 days on the company’s website. Gentherm specializes in heating and cooling systems for automotive and medical applications, employing over 11,000 people globally.

Gentherm (NASDAQ: THRM) has received FDA 510(k) clearance for its ASTOPAD Patient Warming System, designed to prevent and treat hypothermia during surgical procedures. This system, which has been used internationally since 1989, features a silent electronic controller and proprietary warming blankets with precise temperature settings ranging from 32°C to 39°C. The innovative carbon fiber heating technology ensures enhanced patient safety and reliability, making it suitable for hospital environments. The ASTOPAD system meets all relevant medical safety standards.